JENNISON ASSOCIATES LLC - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 272 filers reported holding SAGE THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.97 and the average weighting 0.3%.

Quarter-by-quarter ownership
JENNISON ASSOCIATES LLC ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$33,070,000
-30.8%
582,120
-8.8%
0.02%
-37.1%
Q1 2021$47,779,000
-2.1%
638,326
+13.2%
0.04%0.0%
Q4 2020$48,789,000
+82.1%
563,968
+28.7%
0.04%
+59.1%
Q3 2020$26,793,000
+195.3%
438,365
+100.9%
0.02%
+175.0%
Q2 2020$9,074,000
+45.2%
218,238
+0.3%
0.01%0.0%
Q1 2020$6,251,000
-83.1%
217,667
-57.4%
0.01%
-78.4%
Q4 2019$36,919,000
-91.0%
511,409
-82.5%
0.04%
-91.5%
Q3 2019$410,164,000
-24.2%
2,923,689
-1.0%
0.43%
-19.4%
Q2 2019$540,832,000
+44.4%
2,953,913
+25.4%
0.54%
+44.4%
Q1 2019$374,660,000
+336.7%
2,355,614
+163.0%
0.37%
+287.5%
Q4 2018$85,796,000
-25.0%
895,664
+10.5%
0.10%
-8.6%
Q3 2018$114,444,000
-9.2%
810,224
+0.6%
0.10%
-14.6%
Q2 2018$126,063,000
-1.1%
805,361
+1.8%
0.12%
-3.1%
Q1 2018$127,410,000
+14.0%
791,023
+16.5%
0.13%
+15.5%
Q4 2017$111,790,000
+69.8%
678,707
-35.8%
0.11%
+61.8%
Q3 2017$65,836,000
-38.2%
1,056,750
-20.9%
0.07%
-39.8%
Q2 2017$106,457,000
+12.5%
1,336,728
+0.4%
0.11%
+10.8%
Q1 2017$94,660,000
+95.5%
1,331,922
+40.4%
0.10%
+88.9%
Q4 2016$48,429,000
+27.4%
948,475
+14.9%
0.05%
+31.7%
Q3 2016$38,026,000
+191.2%
825,744
+90.5%
0.04%
+192.9%
Q2 2016$13,059,000
-5.6%
433,411
+0.4%
0.01%
-6.7%
Q1 2016$13,835,000
-7.0%
431,545
+69.1%
0.02%0.0%
Q4 2015$14,875,000255,1450.02%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Finepoint Capital LP 475,600$15,362,0005.31%
Integral Health Asset Management, LLC 412,257$13,316,0002.74%
Palo Alto Investors LP 851,409$27,501,0002.40%
Boxer Capital, LLC 1,094,000$35,336,0002.24%
DAFNA Capital Management LLC 180,306$5,824,0001.59%
Ikarian Capital, LLC 250,000$8,075,0001.47%
Bellevue Group AG 2,973,178$96,034,0001.36%
SECTOR GAMMA AS 118,476$3,827,0000.86%
Artal Group S.A. 450,000$14,535,0000.78%
Diametric Capital, LP 19,393$626,0000.46%
View complete list of SAGE THERAPEUTICS INC shareholders